182 related articles for article (PubMed ID: 36252148)
21. Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 years.
Shimon I; Hirsch D; Tsvetov G; Robenshtok E; Akirov A; Fraenkel M; Eizenberg Y; Herzberg D; Barzilay-Yoseph L; Livner A; Friedrich I; Manisterski Y; Ishay A; Yoel U; Masri H
Endocrine; 2019 Sep; 65(3):656-661. PubMed ID: 31154607
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients.
Vilar L; Freitas MC; Naves LA; Casulari LA; Azevedo M; Montenegro R; Barros AI; Faria M; Nascimento GC; Lima JG; Nóbrega LH; Cruz TP; Mota A; Ramos A; Violante A; Lamounier Filho A; Gadelha MR; Czepielewski MA; Glezer A; Bronstein MD
J Endocrinol Invest; 2008 May; 31(5):436-44. PubMed ID: 18560262
[TBL] [Abstract][Full Text] [Related]
23. Levodopa-refractory hyperprolactinemia and pituitary findings in inherited disorders of biogenic amine metabolism.
Yıldız Y; Kuseyri Hübschmann O; Akgöz Karaosmanoğlu A; Manti F; Karaca M; Schwartz IVD; Pons R; López-Laso E; Palacios NAJ; Porta F; Kavecan I; Balcı MC; Dy-Hollins ME; Wong SN; Oppebøen M; Medeiros LS; de Paula LCP; García-Cazorla A; Hoffmann GF; Jeltsch K; Leuzzi V; Gökçay G; Hübschmann D; Harting I; Özön ZA; Sivri S; Opladen T
J Inherit Metab Dis; 2024 May; 47(3):431-446. PubMed ID: 37452721
[TBL] [Abstract][Full Text] [Related]
24. Speed of response to dopaminergic agents in prolactinomas.
Hage C; Salvatori R
Endocrine; 2022 Mar; 75(3):883-888. PubMed ID: 34846682
[TBL] [Abstract][Full Text] [Related]
25. Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study.
Nachtigall LB; Valassi E; Lo J; McCarty D; Passeri J; Biller BM; Miller KK; Utz A; Grinspoon S; Lawson EA; Klibanski A
Clin Endocrinol (Oxf); 2010 Jan; 72(1):53-8. PubMed ID: 19508591
[TBL] [Abstract][Full Text] [Related]
26. Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.
Zaidi HA; Cote DJ; Castlen JP; Burke WT; Liu YH; Smith TR; Laws ER
World Neurosurg; 2017 Jan; 97():2-7. PubMed ID: 27671881
[TBL] [Abstract][Full Text] [Related]
27. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels.
Greenman Y; Tordjman K; Stern N
Clin Endocrinol (Oxf); 1998 May; 48(5):547-53. PubMed ID: 9666865
[TBL] [Abstract][Full Text] [Related]
28. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.
Colao A; Di Sarno A; Cappabianca P; Di Somma C; Pivonello R; Lombardi G
N Engl J Med; 2003 Nov; 349(21):2023-33. PubMed ID: 14627787
[TBL] [Abstract][Full Text] [Related]
29. Prolactinomas.
Wildemberg LE; Fialho C; Gadelha MR
Presse Med; 2021 Dec; 50(4):104080. PubMed ID: 34687915
[TBL] [Abstract][Full Text] [Related]
30. Women with prolactinomas presented at the postmenopausal period.
Shimon I; Bronstein MD; Shapiro J; Tsvetov G; Benbassat C; Barkan A
Endocrine; 2014 Dec; 47(3):889-94. PubMed ID: 24711223
[TBL] [Abstract][Full Text] [Related]
31. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
[TBL] [Abstract][Full Text] [Related]
32. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
Boyar RM; Kapen S; Finkelstein JW; Perlow M; Sassin JF; Fukushima DK; Weitzman ED; Hellman L
J Clin Invest; 1974 Jun; 53(6):1588-98. PubMed ID: 4208470
[TBL] [Abstract][Full Text] [Related]
33. Galactorrhea and hyperprolactinemia.
Sakiyama R; Quan M
Obstet Gynecol Surv; 1983 Dec; 38(12):689-700. PubMed ID: 6361641
[TBL] [Abstract][Full Text] [Related]
34. Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases.
Eren E; Yapıcı Ş; Çakır ED; Ceylan LA; Sağlam H; Tarım Ö
J Clin Res Pediatr Endocrinol; 2011; 3(2):65-9. PubMed ID: 21750634
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility.
Souter I; Baltagi LM; Toth TL; Petrozza JC
Fertil Steril; 2010 Aug; 94(3):1159-62. PubMed ID: 20116788
[TBL] [Abstract][Full Text] [Related]
36. Clinical presentation of hyperprolactinemia.
Luciano AA
J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
[TBL] [Abstract][Full Text] [Related]
37. Different Cabergoline Effect on Metabolic and Anthropometric Parameters in Female Prolactinoma Patients Versus Idiopathic Hyperprolactinemia Patients.
Aboelnaga MM; Eladawy EH; Elshafei MM; Abdullah N; Shaer ME
Endocr Metab Immune Disord Drug Targets; 2019; 19(4):511-518. PubMed ID: 30806330
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic evaluation of hyperprolactinemia.
Biller BM
J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
[TBL] [Abstract][Full Text] [Related]
39. Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center.
Chutpiboonwat P; Yenpinyosuk K; Sridama V; Kunjan S; Klaimukh K; Snabboon T
Pan Afr Med J; 2020; 36():8. PubMed ID: 32550971
[TBL] [Abstract][Full Text] [Related]
40. Mild hyperprolactinemia in a couple: What impact on fertility?
Maiter D
Ann Endocrinol (Paris); 2022 Jun; 83(3):164-167. PubMed ID: 35525260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
